Deutsche Bank
BNTX icon

Deutsche Bank’s BioNTech BNTX Stock Holding History

Deutsche Bank’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.1M Sell
377,432
-14,257
-4% -$1.34M 0.01% 734
2026
Q1 		$34.8M Sell
391,689
-54,594
-12% -$5.61M 0.01% 722
2025
Q4 		$42.5M Buy
446,283
+63,807
+17% +$6.43M 0.01% 682
2025
Q3 		$37.7M Buy
382,476
+36,910
+11% +$3.95M 0.01% 687
2025
Q2 		$36.8M Buy
345,566
+55,778
+19% +$5.63M 0.01% 664
2025
Q1 		$26.4M Sell
289,788
-14,712
-5% -$1.65M 0.01% 760
2024
Q4 		$34.7M Buy
304,500
+6,749
+2% +$770K 0.01% 722
2024
Q3 		$35.4M Sell
297,751
-52,803
-15% -$4.85M 0.01% 692
2024
Q2 		$28.2M Sell
350,554
-146,914
-30% -$13.4M 0.01% 719
2024
Q1 		$45.9M Sell
497,468
-39,385
-7% -$3.78M 0.02% 581
2023
Q4 		$56.7M Sell
536,853
-9,622
-2% -$970K 0.03% 487
2023
Q3 		$59.4M Sell
546,475
-39,786
-7% -$4.4M 0.04% 426
2023
Q2 		$63.3M Sell
586,261
-33,597
-5% -$3.78M 0.03% 451
2023
Q1 		$77.2M Buy
619,858
+11,266
+2% +$1.55M 0.04% 391
2022
Q4 		$91.4M Sell
608,592
-39,727
-6% -$6.11M 0.05% 342
2022
Q3 		$87.4M Sell
648,319
-2,201
-0.3% -$336K 0.05% 321
2022
Q2 		$97M Buy
650,520
+130,824
+25% +$20M 0.05% 321
2022
Q1 		$88.6M Sell
519,696
-102,237
-16% -$17.2M 0.04% 406
2021
Q4 		$160M Buy
621,933
+348,243
+127% +$95.4M 0.07% 258
2021
Q3 		$74.7M Sell
273,690
-130,425
-32% -$41.5M 0.04% 469
2021
Q2 		$90.5M Sell
404,115
-22,111
-5% -$4.17M 0.04% 416
2021
Q1 		$46.5M Buy
426,226
+299,332
+236% +$31.8M 0.03% 614
2020
Q4 		$10.3M Sell
126,894
-372,755
-75% -$36.6M 0.01% 1024
2020
Q3 		$34.6M Sell
499,649
-25,426
-5% -$1.82M 0.02% 553
2020
Q2 		$35M Buy
525,075
+498,260
+1,858% +$24.9M 0.03% 535
2020
Q1 		$1.57M Sell
26,815
-8,185
-23% -$319K ﹤0.01% 1852
2019
Q4 		$1.19M Buy
+35,000
New +$784K ﹤0.01% 2273

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Deutsche Bank's BNTX Position: Q2 2026 in Review

Deutsche Bank reduced its BioNTech (BNTX) stake by 3.6% in Q2 2026, selling an estimated $1.34M and leaving 377,432 shares worth $35.1M. The position accounts for 0.01% of the portfolio, ranked #734.

Deutsche Bank first reported a position in BNTX in Q4 2019 and has held it in 27 quarters since. The position peaked at $160M in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Deutsche Bank held 377,432 shares of BioNTech worth $35.1M as of Q2 2026.
  • Deutsche Bank sold 14,257 BioNTech shares in Q2 2026, an estimated $1.34M.
  • BioNTech made up 0.01% of Deutsche Bank's portfolio in Q2 2026, its #734 holding.
  • Deutsche Bank first reported a position in BioNTech in Q4 2019 and has held it in 27 quarters since.
  • Deutsche Bank's BioNTech position peaked at $160M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.